Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 30, No. 2, 2010
Issue release date: September 2010
Section title: Review Article
Free Access
Dement Geriatr Cogn Disord 2010;30:161–178

Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy

Olazarán J.a · Reisberg B.i · Clare L.e · Cruz I.a · Peña-Casanova J.a, d · del Ser T.a, b · Woods B.e · Beck C.j · Auer S.m · Lai C.n · Spector A.f · Fazio S.k · Bond J.g · Kivipelto M.o · Brodaty H.p · Rojo J.M.c · Collins H.h · Teri L.l · Mittelman M.i · Orrell M.f · Feldman H.H.q, r · Muñiz R.a
aMaria Wolff Foundation, bNoscira and cSuperior Council of Scientific Research, Madrid, and dHospital del Mar and Municipal Institute of Medical Research, Barcelona, Spain; eBangor University, Bangor, fUniversity College London, London, gNewcastle University, Newcastle, and hCochrane Dementia and Cognitive Improvement Group, Oxford, UK; iNew York University Medical Center, New York, N.Y., jUniversity of Arkansas for Medical Sciences, Little Rock, Ark., kAlzheimer’s Association, Chicago, Ill., and lUniversity of Washington School of Nursing, Seattle, Wash., USA; mMAS Alzheimerhelp, Bad Ischl, Austria; nHong Kong Polytechnic University, Hong Kong, SAR, China; oKarolinska Institutet, Stockholm, Sweden; pUniversity of New South Wales, Sydney, N.S.W., Australia; qDivision of Neurology, University of British Columbia, Vancouver, B.C., Canada, and rNeuroscience, Bristol Myers Squibb, Wallingford, Conn., USA
email Corresponding Author

Ruben Muñiz

Maria Wolff Foundation

Río Sil 15

ES–28669 Boadilla del Monte, Madrid (Spain)

Tel. +34 609 170 712, Fax +34 916 320 363, E-Mail ruben@mariawolff.es

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Introduction: Nonpharmacological therapies (NPTs) can improve the quality of life (QoL) of people with Alzheimer’s disease (AD) and their carers. The objective of this study was to evaluate the best evidence on the effects of NPTs in AD and related disorders (ADRD) by performing a systematic review and meta-analysis of the entire field. Methods: Existing reviews and major electronic databases were searched for randomized controlled trials (RCTs). The deadline for study inclusion was September 15, 2008. Intervention categories and outcome domains were predefined by consensus. Two researchers working together detected 1,313 candidate studies of which 179 RCTs belonging to 26 intervention categories were selected. Cognitive deterioration had to be documented in all participants, and degenerative etiology (indicating dementia) had to be present or presumed in at least 80% of the subjects. Evidence tables, meta-analysis and summaries of results were elaborated by the first author and reviewed by author subgroups. Methods for rating level of evidence and grading practice recommendations were adapted from the Oxford Center for Evidence-Based Medicine. Results: Grade A treatment recommendation was achieved for institutionalization delay (multicomponent interventions for the caregiver, CG). Grade B recommendation was reached for the person with dementia (PWD) for: improvement in cognition (cognitive training, cognitive stimulation, multicomponent interventions for the PWD); activities of daily living (ADL) (ADL training, multicomponent interventions for the PWD); behavior (cognitive stimulation, multicomponent interventions for the PWD, behavioral interventions, professional CG training); mood (multicomponent interventions for the PWD); QoL (multicomponent interventions for PWD and CG) and restraint prevention (professional CG training); for the CG, grade B was also reached for: CG mood (CG education, CG support, multicomponent interventions for the CG); CG psychological well-being (cognitive stimulation, multicomponent interventions for the CG); CG QoL (multicomponent interventions for PWD and CG). Conclusion: NPTs emerge as a useful, versatile and potentially cost-effective approach to improve outcomes and QoL in ADRD for both the PWD and CG.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review Article

Accepted: May 26, 2010
Published online: September 10, 2010
Issue release date: September 2010

Number of Print Pages: 18
Number of Figures: 3
Number of Tables: 2

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: http://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.